SION
Sionna Therapeutics, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.69B
P/E Ratio
—
EPS
$-1.88
Beta
—
52W High
$46.46
52W Low
$11.77
50-Day MA
$38.10
200-Day MA
$33.85
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Sionna Therapeutics, Inc. Common Stock
Sionna Therapeutics, Inc. is a pioneering biotechnology company dedicated to developing innovative therapies for neurodegenerative diseases, particularly those characterized by protein misfolding and aggregation, including Alzheimer's and Parkinson's diseases. With a strong emphasis on proprietary technologies and a scientifically robust pipeline, Sionna is addressing critical unmet medical needs in this space. The company's strategic collaborations and commitment to research and development solidify its role as a significant contender in the biopharmaceutical sector, with a mission to enhance patient quality of life through groundbreaking advancements in neurology.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-88.33M |
| Operating Margin | 0.00% |
| Return on Equity | -31.80% |
| Return on Assets | -21.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $6.86 |
| Price-to-Book | 5.49 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $45.14M |
| Float | $16.35M |
| % Insiders | 6.85% |
| % Institutions | 96.85% |
Historical Volatility
HV 10-Day
71.44%
HV 20-Day
77.40%
HV 30-Day
75.78%
HV 60-Day
71.77%
HV Rank
36.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($50.33 target)
1
Strong Buy8
Buy1
Strong SellData last updated: 4/30/2026